Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Mineralys Therapeutics, Inc. (MLYS) since 2023 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Mineralys Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1933414.
Total stock buying since 2023: $88,905,524.
Total stock sales since 2023: $16,618,083.
Total stock option exercises since 2023: $367,129.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 2,755,555 | $37,199,992 | 268,086 | $3,758,211 | 57,413 | $58,930 |
| 2024 | 555,555 | $7,499,992 | 755,774 | $9,865,472 | 153,828 | $132,532 |
| 2023 | 2,767,000 | $44,205,540 | 231,716 | $2,994,400 | 246,768 | $175,667 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 0 | $0 | 11,365 | $146,983 | 6,349 | $6,856 |
| 2025-07 | 0 | $0 | 111,686 | $1,637,741 | 6,349 | $6,856 |
| 2025-06 | 0 | $0 | 11,366 | $165,932 | 6,348 | $6,855 |
| 2025-05 | 0 | $0 | 11,366 | $173,774 | 6,349 | $6,856 |
| 2025-04 | 0 | $0 | 93,213 | $1,367,007 | 7,954 | $8,589 |
| 2025-03 | 2,755,555 | $37,199,992 | 0 | $0 | 6,349 | $6,856 |
| 2025-02 | 0 | $0 | 0 | $0 | 6,348 | $6,855 |
| 2025-01 | 0 | $0 | 29,090 | $266,774 | 11,367 | $9,207 |
| 2024-12 | 0 | $0 | 0 | $0 | 5,017 | $2,709 |
| 2024-11 | 0 | $0 | 30,508 | $458,470 | 35,525 | $35,654 |
| 2024-10 | 0 | $0 | 26,028 | $352,437 | 10,369 | $8,489 |
| 2024-09 | 0 | $0 | 0 | $0 | 11,367 | $9,565 |
| 2024-08 | 0 | $0 | 0 | $0 | 11,365 | $9,205 |
| 2024-07 | 0 | $0 | 577,028 | $7,536,848 | 11,891 | $10,132 |
| 2024-06 | 0 | $0 | 122,110 | $1,516,217 | 11,366 | $9,565 |
| 2024-05 | 0 | $0 | 100 | $1,500 | 11,466 | $9,314 |
| 2024-04 | 0 | $0 | 0 | $0 | 11,366 | $9,565 |
| 2024-03 | 0 | $0 | 0 | $0 | 11,365 | $9,564 |
| 2024-02 | 555,555 | $7,499,992 | 0 | $0 | 11,366 | $9,206 |
| 2024-01 | 0 | $0 | 0 | $0 | 11,365 | $9,564 |
| 2023-12 | 0 | $0 | 0 | $0 | 5,018 | $2,709 |
| 2023-11 | 4,250 | $25,355 | 0 | $0 | 10,034 | $5,418 |
| 2023-09 | 2,250 | $27,180 | 0 | $0 | 0 | $0 |
| 2023-08 | 4,250 | $53,005 | 231,716 | $2,994,400 | 231,716 | $167,540 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-13 | Rodman David Malcom (Chief Medical Officer) | Sale | 11,365 | 12.93 | 146,983 |
| 2025-08-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,349 | 1.08 | 6,856 |
| 2025-07-30 | Levy Adam Scott (CFO and Secretary) | Sale | 59,925 | 14.90 | 892,882 |
| 2025-07-29 | Levy Adam Scott (CFO and Secretary) | Sale | 807 | 14.01 | 11,302 |
| 2025-07-28 | Levy Adam Scott (CFO and Secretary) | Sale | 12,946 | 14.04 | 181,800 |
| 2025-07-14 | Rodman David Malcom (Chief Medical Officer) | Sale | 11,366 | 14.59 | 165,875 |
| 2025-07-14 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,349 | 1.08 | 6,856 |
| 2025-07-11 | Levy Adam Scott (CFO and Secretary) | Sale | 10,758 | 14.45 | 155,453 |
| 2025-07-11 | Congleton Jon (Chief Executive Officer) | Sale | 15,884 | 14.51 | 230,429 |
| 2025-06-13 | Rodman David Malcom (Chief Medical Officer) | Sale | 11,366 | 14.60 | 165,932 |
| 2025-06-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,348 | 1.08 | 6,855 |
| 2025-05-14 | Rodman David Malcom (Chief Medical Officer) | Sale | 11,366 | 15.29 | 173,774 |
| 2025-05-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,349 | 1.08 | 6,856 |
| 2025-04-14 | Rodman David Malcom (Chief Medical Officer) | Sale | 11,366 | 14.26 | 162,090 |
| 2025-04-14 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,348 | 1.08 | 6,855 |
| 2025-04-11 | Levy Adam Scott (CFO and Secretary) | Sale | 10,757 | 12.06 | 129,686 |
| 2025-04-11 | Congleton Jon (Chief Executive Officer) | Sale | 15,319 | 12.19 | 186,799 |
| 2025-04-01 | Rodman David Malcom (Chief Medical Officer) | Sale | 55,771 | 15.93 | 888,432 |
| 2025-04-01 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 1,606 | 1.08 | 1,734 |
| 2025-03-13 | Catalys Pacific Fund, Lp (10% Owner) | Buy | 259,259 | 13.50 | 3,499,996 |
| 2025-03-13 | Samsara Biocapital, L.p. | Buy | 600,000 | 13.50 | 8,100,000 |
| 2025-03-13 | Shah Rajeev M. | Buy | 1,296,296 | 13.50 | 17,499,996 |
| 2025-03-13 | Akkaraju Srinivas | Buy | 600,000 | 13.50 | 8,100,000 |
| 2025-03-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,349 | 1.08 | 6,856 |
| 2025-02-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,348 | 1.08 | 6,855 |
| 2025-01-13 | Levy Adam Scott (CFO and Secretary) | Sale | 10,757 | 9.36 | 100,696 |
| 2025-01-13 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 11,367 | .81 | 9,207 |
| 2025-01-13 | Congleton Jon (Chief Executive Officer) | Sale | 18,333 | 9.06 | 166,078 |
| 2024-12-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,017 | .54 | 2,709 |
| 2024-11-11 | Rodman David Malcom (Chief Medical Officer) | Sale | 5,026 | 15.00 | 75,400 |
| 2024-11-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 10,043 | .81 | 8,134 |
| 2024-11-06 | Rodman David Malcom (Chief Medical Officer) | Sale | 25,482 | 15.03 | 383,070 |
| 2024-11-06 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 25,482 | 1.08 | 27,520 |
| 2024-10-14 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,352 | 1.08 | 5,780 |
| 2024-10-11 | Levy Adam Scott (CFO and Secretary) | Sale | 10,757 | 13.57 | 146,004 |
| 2024-10-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,017 | .54 | 2,709 |
| 2024-10-11 | Congleton Jon (Chief Executive Officer) | Sale | 15,271 | 13.52 | 206,433 |
| 2024-09-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,349 | 1.08 | 6,856 |
| 2024-09-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,018 | .54 | 2,709 |
| 2024-08-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 11,365 | .81 | 9,205 |
| 2024-07-24 | Catalys Pacific Fund, Lp (10% Owner) | Sale | 550,000 | 13.05 | 7,177,500 |
| 2024-07-16 | Rodman David Malcom (Chief Medical Officer) | Sale | 525 | 15.00 | 7,875 |
| 2024-07-16 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 525 | 1.08 | 567 |
| 2024-07-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,349 | 1.08 | 6,856 |
| 2024-07-11 | Levy Adam Scott (CFO and Secretary) | Sale | 10,757 | 13.14 | 141,390 |
| 2024-07-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,017 | .54 | 2,709 |
| 2024-07-11 | Congleton Jon (Chief Executive Officer) | Sale | 15,746 | 13.34 | 210,083 |
| 2024-06-20 | Congleton Jon (Chief Executive Officer) | Sale | 14,940 | 11.73 | 175,231 |
| 2024-06-18 | Congleton Jon (Chief Executive Officer) | Sale | 16,607 | 11.99 | 199,068 |
| 2024-06-17 | Congleton Jon (Chief Executive Officer) | Sale | 17,766 | 12.25 | 217,704 |
| 2024-06-14 | Congleton Jon (Chief Executive Officer) | Sale | 16,229 | 12.52 | 203,170 |
| 2024-06-13 | Congleton Jon (Chief Executive Officer) | Sale | 39,961 | 12.74 | 509,023 |
| 2024-06-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,349 | 1.08 | 6,856 |
| 2024-06-12 | Congleton Jon (Chief Executive Officer) | Sale | 16,607 | 12.77 | 212,021 |
| 2024-06-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,017 | .54 | 2,709 |
| 2024-05-13 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 11,366 | .81 | 9,206 |
| 2024-05-09 | Rodman David Malcom (Chief Medical Officer) | Sale | 100 | 15.00 | 1,500 |
| 2024-05-09 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 100 | 1.08 | 108 |
| 2024-04-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,349 | 1.08 | 6,856 |
| 2024-04-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,017 | .54 | 2,709 |
| 2024-03-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,348 | 1.08 | 6,855 |
| 2024-03-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,017 | .54 | 2,709 |
| 2024-02-12 | Samsara Biocapital, L.p. | Buy | 555,555 | 13.50 | 7,499,992 |
| 2024-02-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 11,366 | .81 | 9,206 |
| 2024-01-12 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 6,348 | 1.08 | 6,855 |
| 2024-01-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,017 | .54 | 2,709 |
| 2023-12-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 5,018 | .54 | 2,709 |
| 2023-11-22 | Congleton Jon (Chief Executive Officer) | Buy | 4,250 | 5.97 | 25,355 |
| 2023-11-03 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 10,034 | .54 | 5,418 |
| 2023-09-06 | Congleton Jon (Chief Executive Officer) | Buy | 2,250 | 12.08 | 27,180 |
| 2023-08-17 | Congleton Jon (Chief Executive Officer) | Buy | 2,250 | 12.10 | 27,225 |
| 2023-08-11 | Rodman David Malcom (Chief Medical Officer) | Sale | 157,091 | 12.81 | 2,012,335 |
| 2023-08-11 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 157,091 | .81 | 127,243 |
| 2023-08-11 | Congleton Jon (Chief Executive Officer) | Buy | 2,000 | 12.89 | 25,780 |
| 2023-08-10 | Rodman David Malcom (Chief Medical Officer) | Sale | 74,625 | 13.16 | 982,065 |
| 2023-08-10 | Rodman David Malcom (Chief Medical Officer) | Option Ex | 74,625 | .54 | 40,297 |
| 2023-02-14 | Catalys Pacific Fund, Lp | Buy | 250,000 | 16.00 | 4,000,000 |
| 2023-02-14 | Samsara Biocapital, L.p. | Buy | 937,500 | 16.00 | 15,000,000 |
| 2023-02-14 | Levy Adam Scott (CFO, Chief Bus. Off. and Secy.) | Buy | 6,250 | 16.00 | 100,000 |
| 2023-02-14 | Shah Rajeev M. | Buy | 1,250,000 | 16.00 | 20,000,000 |
| 2023-02-14 | Hbm Healthcare Investments (cayman) Ltd. | Buy | 312,500 | 16.00 | 5,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of MLYS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Mineralys Therapeutics, Inc. (symbol MLYS, CIK number 1933414) see the Securities and Exchange Commission (SEC) website.